KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,850
+100 (0.85%)
At close: Apr 29, 2026
-18.22%
Market Cap 128.15B
Revenue (ttm) 87.60B
Net Income (ttm) -2.64B
Shares Out 10.91M
EPS (ttm) -242.00
PE Ratio n/a
Forward PE n/a
Dividend 50.00 (0.42%)
Ex-Dividend Date Dec 29, 2025
Volume 10,805
Average Volume 20,165
Open 11,850
Previous Close 11,750
Day's Range 11,650 - 11,900
52-Week Range 10,780 - 18,710
Beta 0.85
RSI 52.24
Earnings Date n/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.